GlaxoSmithKline plc (LON:GSK)‘s stock had its “buy” rating reaffirmed by research analysts at HSBC in a research note issued to investors on Monday. They presently have a GBX 1,970 ($24.61) target price on the stock. HSBC’s price target would indicate a potential upside of 27.88% from the company’s current price.
GSK has been the topic of a number of other reports. Credit Suisse Group AG reissued a “neutral” rating and issued a GBX 1,800 ($22.49) price objective on shares of GlaxoSmithKline plc in a research note on Thursday, July 14th. S&P Global Inc. set a GBX 1,650 ($20.61) target price on shares of GlaxoSmithKline plc and gave the company a “neutral” rating in a report on Wednesday, July 27th. BNP Paribas restated a “neutral” rating on shares of GlaxoSmithKline plc in a report on Friday, July 29th. Goldman Sachs Group Inc. restated a “buy” rating and issued a GBX 1,800 ($22.49) target price on shares of GlaxoSmithKline plc in a report on Thursday, October 27th. Finally, Citigroup Inc. set a GBX 1,800 ($22.49) target price on shares of GlaxoSmithKline plc and gave the company a “buy” rating in a report on Thursday, September 29th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and nine have assigned a buy rating to the company. GlaxoSmithKline plc has a consensus rating of “Hold” and an average price target of GBX 1,734.57 ($21.67).
Shares of GlaxoSmithKline plc (LON:GSK) traded up 1.15% on Monday, hitting GBX 1540.50. 7,445,723 shares of the company were exchanged. The firm’s market cap is GBX 74.96 billion. The company has a 50-day moving average price of GBX 1,604.18 and a 200 day moving average price of GBX 1,586.69. GlaxoSmithKline plc has a 52-week low of GBX 1,277.25 and a 52-week high of GBX 1,745.56.
The business also recently declared a dividend, which will be paid on Thursday, January 12th. Stockholders of record on Thursday, November 3rd will be given a dividend of GBX 19 ($0.24) per share. This represents a dividend yield of 1.17%. The ex-dividend date is Thursday, November 3rd.
In other news, insider Sir Andrew P. Witty sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 27th. The shares were sold at an average price of GBX 1,636 ($20.44), for a total transaction of £163,600 ($204,397.80). Also, insider Manvinder Singh Banga purchased 1,750 shares of the firm’s stock in a transaction dated Wednesday, October 26th. The shares were bought at an average cost of GBX 1,643 ($20.53) per share, with a total value of £28,752.50 ($35,922.66).